174 related articles for article (PubMed ID: 35184747)
1. Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
Liu W; Jiang Q; Sun C; Liu S; Zhao Z; Wu D
BMC Cancer; 2022 Feb; 22(1):192. PubMed ID: 35184747
[TBL] [Abstract][Full Text] [Related]
2. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
Li N; Yu K; Lin Z; Zeng D
Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
4. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
Zhen Z; Shen Z; Hu Y; Sun P
Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
[TBL] [Abstract][Full Text] [Related]
7. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
8. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Zengin T; Önal-Süzek T
BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
14. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
15. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
17. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
18. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
19. Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer.
Zheng J; Cao B; Zhang X; Niu Z; Tong J
Biomed Res Int; 2020; 2020():3641231. PubMed ID: 33274204
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer.
Wang J; Zhang C
Bioengineered; 2021 Dec; 12(1):898-913. PubMed ID: 33682613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
